September 2026
The global genotyping assays market size is evaluated at USD 22.14 billion in 2025 and is predicted to hit around USD 79.12 billion by 2035, growing at a CAGR of 13.58%.
September 2026
The single nucleotide polymorphism (SNP) genotyping market size was USD 9.11 billion in 2026, with leading single nucleotide polymorphism (SNP) genotyping market players including QIAGEN N.V, Bio-Rad Laboratories.
September 2026
The global multiplex assays market size was estimated at USD 2.30 billion in 2026 and is expected to hit around USD 7.51 billion by 2035, growing at a CAGR of 14.15%.
September 2026
The oxidative stress assays market size was valued at USD 1.39 billion in 2026 and is expected to hit around USD 3.33 billion by 2035, growing at a CAGR of 9.13%.
September 2026
The apoptosis assays market size stood at USD 3.19 billion in 2026, with major apoptosis assays market companies including Thermo Fisher Scientific Inc, Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Danaher Corporation, Promega Corporation.
February 2026
The global cell-based assays market size is projected to hit around USD 44.23 billion by 2035 from USD 19.78 billion in 2025 with a CAGR of 8.38%.
February 2026
The global genotyping market size was estimated at USD 25.62 billion in 2025 and is expected to surpass around USD 91.85 billion by 2035, growing at a CAGR of 13.62%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com